NASDAQ: OCGN

Ocugen Inc Stock Forecast, Predictions & Price Target

The consensus among 2 Wall Street analysts covering (NASDAQ: OCGN) stock is to Strong Buy OCGN stock.

Out of 2 analysts, 1 (50%) are recommending OCGN as a Strong Buy, 1 (50%) are recommending OCGN as a Buy, 0 (0%) are recommending OCGN as a Hold, 0 (0%) are recommending OCGN as a Sell, and 0 (0%) are recommending OCGN as a Strong Sell.

If you're new to stock investing, here's how to buy Ocugen stock.

(NASDAQ: OCGN) Ocugen's forecast annual revenue growth rate of 51.02% is forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 37.57%, and it is also forecast to beat the US market's average forecast revenue growth rate of 10.16%.

Ocugen's revenue in 2024 is $6,036,000.On average, 1 Wall Street analysts forecast OCGN's revenue for 2025 to be $10,375,354,644, with the lowest OCGN revenue forecast at $10,375,354,644, and the highest OCGN revenue forecast at $10,375,354,644. On average, 1 Wall Street analysts forecast OCGN's revenue for 2026 to be $5,293,180,680, with the lowest OCGN revenue forecast at $5,293,180,680, and the highest OCGN revenue forecast at $5,293,180,680.

In 2027, OCGN is forecast to generate $21,900,953,219 in revenue, with the lowest revenue forecast at $21,900,953,219 and the highest revenue forecast at $21,900,953,219.

According to 2 Wall Street analysts that have issued a 1 year OCGN price target, the average OCGN price target is $6.00, with the highest OCGN stock price forecast at $7.00 and the lowest OCGN stock price forecast at $5.00.

On average, Wall Street analysts predict that Ocugen's share price could reach $6.00 by Apr 22, 2025. The average Ocugen stock price prediction forecasts a potential upside of 380% from the current OCGN share price of $1.25.

(NASDAQ: OCGN) forecast ROE is N/A, which is considered weak.